Megan S. Joseph

Megan S. Joseph

Auto-generated profile, based on publicly available information

Megan S. Joseph

Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan Medical School and Michigan Medicine, Ann Arbor, Michigan, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2021 in Cardiorenal Medicine
Verified
Journal Article
Open access
PDF file
MJMegan S. Joseph
Megan S. Joseph
FTFrancis Tinney
Francis Tinney
ANAbhijit Naik
Abhijit Naik
RPRaviprasenna Parasuraman
Raviprasenna Parasuraman
MSMilagros Samaniego-Picota
Milagros Samaniego-Picota
NBNicole M. Bhave
Nicole M. Bhave
Introduction: Pulmonary hypertension is common among patients with end-stage renal disease, although data regarding the impact of right ventricular (RV) failure on postoperative outcomes remain limited. We hypothesized that echocardiographic findings of RV dilation and dysfunction are associated with adverse clinical outcomes after renal transplant. Methods: A retrospective review of adult renal transplant recipients at a single institution from January 2008 to June 2010 was conducted. Patients with transthoracic echocardiograms (TTEs) within 1 year leading up to transplant were included. The primary end point was a composite of delayed graft function, graft failure, and all-cause mortality. Results: Eighty patients were included. Mean follow-up time was 9.4 ± 0.8 years. Eight patients (100%) with qualitative RV dysfunction met the primary end point, while 39/65 patients (60.0%) without RV dysfunction met the end point (p = 0.026). Qualitative RV dilation was associated with a significantly shorter time to all-cause graft failure (p = 0.03) and death (p = 0.048). RV systolic pressure was not measurable in 45/80 patients (56%) and was not associated with outcomes in the remaining patients. Conclusion: RV dilation and dysfunction are associated with adverse outcomes after renal transplant. TTE assessment of RV size and function should be a standard part of the pre-kidney transplant cardiovascular risk assessment.

19 October 2026 in Journal of Cardiovascular Computed Tomography
Verified
Journal Article
Open access
DCDakota De Cecco
Dakota De Cecco
CSChristopher Scoma
Christopher Scoma
CPCorey Powell
Corey Powell
MJMegan Joseph
Megan Joseph
WTWilliam Truesdell
William Truesdell
AHAndrew W. Harris
Andrew W. Harris